Literature DB >> 19644906

Health-related quality of life in systemic sclerosis: a systematic review.

Marie Hudson1, Brett D Thombs, Russell Steele, Pantelis Panopalis, Evan Newton, Murray Baron.   

Abstract

OBJECTIVE: A number of studies (all n <200) have assessed health-related quality of life (HRQOL) in patients with systemic sclerosis (SSc), but no systematic review of the effect of SSc on HRQOL has been done. The objective of this study was to systematically review the literature on HRQOL in SSc measured using the Medical Outcomes Trust Short Form 36 (SF-36).
METHODS: A comprehensive search was conducted in August 2007 using Medline, CINAHL, and EMBase to identify original research studies reporting SF-36 scores of SSc patients. Selected studies were reviewed and characteristics of the study samples and SF-36 data were extracted. Bayesian meta-analysis and meta-regression were performed to obtain pooled estimates of SF-36 physical component summary (PCS) and mental component summary (MCS) scores for all patients as well as by limited and diffuse disease status.
RESULTS: Twelve data sets with a total of 1,127 SSc patients were included in the systematic review. HRQOL was impaired in patients with SSc, with pooled SF-36 PCS scores being more than 1 SD below the general population (38.3; 95% credible interval [95% CI] 35.2, 41.5) and pooled SF-36 MCS scores being approximately 0.5 SDs below the general population (46.6; 95% CI 44.2, 49.1). SF-36 PCS scores were 3.5 points (95% CI -1.0, 8.0) lower in patients with diffuse compared with limited disease.
CONCLUSION: This study provides robust evidence of the presence and magnitude of impairment in HRQOL in patients with SSc. Although the impairment appears greater in physical health, mental health impairment is also reported.

Entities:  

Mesh:

Year:  2009        PMID: 19644906     DOI: 10.1002/art.24676

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  49 in total

1.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

2.  Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

Authors:  Luiza F Rocha; Roberta G Marangoni; Percival D Sampaio-Barros; Mauricio Levy-Neto; Natalino H Yoshinari; Eloisa Bonfa; Virginia Steen; Sergio C Kowalski
Journal:  Clin Rheumatol       Date:  2013-08-22       Impact factor: 2.980

3.  Association between cortisol levels and pain threshold in systemic sclerosis and major depression.

Authors:  Gianluca Bagnato; Francesca Cordova; Davide Sciortino; Giovanni Miceli; Antonio Bruno; Antonino Ferrera; Donatella Sangari; Giovanni Coppolino; Maria R A Muscatello; Gianluca Pandolfo; Rocco A Zoccali; William N Roberts
Journal:  Rheumatol Int       Date:  2017-10-30       Impact factor: 2.631

4.  Clinical Efficacy and Safety of Bathing with Chinese Medicine Taohong Siwu Decoction () for Treatment of Diffuse Cutaneous Systemic Sclerosis: A Randomized Placebo-Controlled Trial.

Authors:  Jing Zhou; Dong Yang; Shu-Hong Zhou; Jin-Ping Wang; Yue-Shu Liu; Shu-Lan Wang
Journal:  Chin J Integr Med       Date:  2017-02-15       Impact factor: 1.978

5.  Evaluation of dry eye signs and symptoms in patients with systemic sclerosis.

Authors:  Beatriz de A F Gomes; Marcony R Santhiago; Mário N L de Azevedo; Haroldo V Moraes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

6.  The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Authors:  Thomas Hyphantis; Konstantinos Kotsis; Niki Tsifetaki; Francis Creed; Alexandros A Drosos; André F Carvalho; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

7.  Measuring illness behavior in patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Roozbeh Sharif; Brock E Harper; Hilda T Draeger; Emilio B Gonzalez; Deepthi K Nair; Terry A McNearney; Shervin Assassi; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

8.  Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Authors:  Linda Kwakkenbos; Brett D Thombs; Dinesh Khanna; Marie-Eve Carrier; Murray Baron; Daniel E Furst; Karen Gottesman; Frank van den Hoogen; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Warren R Nielson; Serge Poiraudeau; Robert Riggs; Maureen Sauvé; Fredrick Wigley; Marie Hudson; Susan J Bartlett
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

9.  Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS).

Authors:  Sabine Twork; Susanne Wiesmeth; Milena Spindler; Markus Wirtz; Sabine Schipper; Dieter Pöhlau; Jörg Klewer; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-06-07       Impact factor: 3.186

10.  Lower extremity ulcers in systemic sclerosis: features and response to therapy.

Authors:  Victoria K Shanmugam; Patricia Price; Christopher E Attinger; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.